Biomarkers for the efficacy of calcitonin and parathyroid hormone treatment

Details for Australian Patent Application No. 2004294268 (hide)

Owner Novartis AG

Inventors Bobadilla, Maria

Agent Davies Collison Cave

Pub. Number AU-A-2004294268

PCT Pub. Number WO2005/053731

Priority 60/525,025 25.11.03 US

Filing date 24 November 2004

Wipo publication date 16 June 2005

International Classifications

A61K 38/23 (2006.01) Medicinal preparations containing peptides - Calcitonins

A61K 38/29 (2006.01) Medicinal preparations containing peptides - Parathyroid hormone (parathormone)

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/053731 Priority application(s): WO2005/053731

30 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004294269-Biomarkers for the efficacy of somatostatin analogue treatment

2004294266-Method of treating a patient's teeth using fluoride releasing glass composition